Interferon-b Modulates Inflammatory Response in Cerebral Ischemia


Background-—Stroke is a leading cause of death in the world. In >80% of strokes, the initial acute phase of ischemic injury is due to the occlusion of a blood vessel resulting in severe focal hypoperfusion, excitotoxicity, and oxidative damage. Interferon-b (IFNb), a cytokine with immunomodulatory properties, was approved by the US Food and Drug… (More)


7 Figures and Tables